Signifier Medical Technologies Limited ("Signifier"), a global leader in medical technology for sleep-disordered breathing, announced today that eXciteOSA®, its non-invasive daytime therapy for ...

Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...

The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.

In my twenties, I saw my episodes as a (mostly) harmless quirk, akin to sleep walking. They didn’t always keep me in my family’s good graces, but I felt otherwise fine. I brushed them off for years.

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January for information on marketing and reimbursement practices.

An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Signifier Medical secures EU MDR certification for eXciteOSA®, ensuring safety, efficacy, and broader access to its ...

A woman who has suffered with sleep apnoea for a decade is finally able to breathe and sleep again thanks to a new implant.

Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...

Jan 30 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common ...